Marinus Pharmaceuticals Inc (MRNS)
1.33
+0.03
(+2.31%)
USD |
NASDAQ |
May 17, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Max Drawdown (5Y): 94.98% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 94.98% |
March 31, 2024 | 94.98% |
February 29, 2024 | 94.98% |
January 31, 2024 | 94.98% |
December 31, 2023 | 94.98% |
November 30, 2023 | 94.98% |
October 31, 2023 | 94.98% |
September 30, 2023 | 94.98% |
August 31, 2023 | 94.98% |
July 31, 2023 | 94.98% |
June 30, 2023 | 94.98% |
May 31, 2023 | 94.98% |
April 30, 2023 | 94.98% |
March 31, 2023 | 94.98% |
February 28, 2023 | 94.98% |
January 31, 2023 | 94.98% |
December 31, 2022 | 94.98% |
November 30, 2022 | 94.98% |
October 31, 2022 | 94.98% |
September 30, 2022 | 94.98% |
August 31, 2022 | 94.98% |
July 31, 2022 | 94.98% |
June 30, 2022 | 94.98% |
May 31, 2022 | 94.98% |
April 30, 2022 | 94.98% |
Date | Value |
---|---|
March 31, 2022 | 94.98% |
February 28, 2022 | 94.98% |
January 31, 2022 | 94.98% |
December 31, 2021 | 94.98% |
November 30, 2021 | 94.98% |
October 31, 2021 | 94.98% |
September 30, 2021 | 95.69% |
August 31, 2021 | 95.69% |
July 31, 2021 | 95.69% |
June 30, 2021 | 95.69% |
May 31, 2021 | 95.69% |
April 30, 2021 | 95.69% |
March 31, 2021 | 95.69% |
February 28, 2021 | 95.69% |
January 31, 2021 | 95.69% |
December 31, 2020 | 95.69% |
November 30, 2020 | 95.69% |
October 31, 2020 | 95.69% |
September 30, 2020 | 95.69% |
August 31, 2020 | 95.69% |
July 31, 2020 | 95.69% |
June 30, 2020 | 95.69% |
May 31, 2020 | 95.69% |
April 30, 2020 | 95.69% |
March 31, 2020 | 95.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.98%
Minimum
Oct 2021
95.69%
Maximum
May 2019
95.33%
Average
94.98%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
Pfizer Inc | 54.78% |
ACADIA Pharmaceuticals Inc | 77.18% |
Alnylam Pharmaceuticals Inc | 52.27% |
Regeneron Pharmaceuticals Inc | 53.84% |
Actinium Pharmaceuticals Inc | 97.29% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -55.83 |
Beta (5Y) | 1.145 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 97.88% |
Historical Sharpe Ratio (5Y) | -0.4401 |
Historical Sortino (5Y) | -0.7118 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.78% |